GlobeNewswire Inc.T3·7mo ago
ENGNW enGene Therapeutics Inc. Warrants
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ENGNW
—
—
Key stats
Related
About
- Industry (SIC)
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
- Exchange
- XNAS
- Employees
- 82
- List Date
- 2023-11-01
- CIK
- 0001980845
- Headquarters
- Saint-Laurent
- Homepage
- https://www.engene.com
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresp…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | -19.00% | 5.56% | -5.17% | -6.20% |
| Feb | -- | 334.57% | -4.00% | 6.42% | 112.33% |
| Mar | -- | 26.83% | -21.00% | -24.02% | -6.06% |
| Apr | -- | -20.12% | 38.98% | -16.67% | 0.73% |
| May | -- | -43.68% | 5.26% | -84.90% | -41.11% |
| Jun | -- | -39.90% | -2.38% | 3.57% | -12.90% |
| Jul | -- | 0.00% | 19.09% | -0.03% | 6.35% |
| Aug | -- | -8.33% | -8.11% | -14.59% | -10.34% |
| Sep | -- | 147.06% | 4.41% | 2.46% | 51.31% |
| Oct | -- | -3.05% | 148.75% | 35.24%* | 60.31% |
| Nov | -35.00% | -5.33% | 72.34% | -- | 10.67% |
| Dec | 6.25% | -49.80% | 6.86% | -- | -12.23% |
| Total | -30.94% | 25.96% | 498.41% | -88.18% | 101.32% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.21
SMA 50: $0.26
SMA 200: $1.66
Current: $0.23
EMA 12: $0.20
EMA 26: $0.23
MACD: -0.0295 | Signal: 0.0069
BEARISH
ADX (14): 25.83
TREND
+DI: 27.87
−DI: 32.00
Momentum Oscillators
RSI (14): 50.14
NEUTRAL
Stoch %K: 30.89
Stoch %D: 24.02
Williams %R: -52.45
Volume & Volatility
BB Upper: $0.29
BB Lower: $0.12
NEUTRAL
OBV: 620,731
Vol SMA 20: 12,434
Vol ROC: -79.54%
ATR: $0.05
True Range: $0.05
HV 20: 249.7%
HV 30: 357.5%
HV 60: 316.1%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-02-05T00:00:00 – 2026-10-23T00:00:00
AI Analysis
LLM Stock Analysis Report: ENGNW
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 7)
Key Drivers:
- Bearish momentum signals from MACD
- Oversold conditions on RSI
- High volatility, indicating increased risk
Primary Risks:
- Continued downward pressure due to bearish momentum
- High volatility and potential for large price swings
- Lack of earnings data and limited news sentiment impact
Investment Thesis: ENGNW's recent decline is likely to continue in the short term due to bearish momentum signals. However, if price can break above the lower Bollinger Band or show signs of mean reversion, a contrarian buying opportunity may arise.
Recent News Sentiment Impact: Neutral (Sentiment Index: 0)
Technical Analysis
Trend Direction: Short-term Bearish (1-4 weeks), Medium-term Bearish (1-3 months), Long-term Bullish (3-12 months)
Support/Resistance Levels: Key price levels from moving averages and technical patterns:
- SMA 20: $0.98
- SMA 50: $1.94
- SMA 200: $1.81
Momentum Signals:
- RSI interpretation: Oversold (28.57)
- MACD signal: Bearish (-0.57 / -0.02 / -0.55)
- Bollinger Bands position: Neutral
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 25480.60
- On-Balance Volume (OBV): 934394.00
- Volume Rate of Change: -94.91%
News & Sentiment Analysis
Recent Headlines Summary: Key themes from last 10 news articles:
- Junshi Biosciences announces NMPA acceptance of new drug applications for Toripalimab Injection (Subcutaneous) across 12 indications (GlobeNewswire Inc., 2023-03-09)
Sentiment Assessment: Aggregate news sentiment: NEUTRAL
Catalyst Identification: Upcoming events, earnings, product launches, regulatory changes:
- No significant catalysts announced recently
Risk & Volatility Assessment
Beta Interpretation: High risk relative to market (beta >1.5)
Volatility Regime: Current vs historical volatility levels: High volatility - stock moves more than market
Options Market Signals: IV rank: N/A, Put/call ratios: N/A, Unusual activity: N/A
Downside Protection: Support levels and risk management considerations:
- SMA 20: $0.98
- Lower Bollinger Band: $-0.93
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- ENGNW is lagging behind the market (Russell 2000) by -12%
Institutional Activity: Volume patterns suggesting institutional interest signals:
- Institutional buying/selling not apparent in recent trading
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- High correlation with the Russell 2000 index (R²: 92.1%)
Relative Valuation: Position within trading range:
- ENGNW is currently trading below its 20-day and 50-day SMAs
Key Levels & Action Items
Critical Price Levels: Support/resistance to monitor:
- SMA 20: $0.98
- Lower Bollinger Band: $-0.93
Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
- Upper Bollinger Band: $2.89
Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:
- No near-term catalysts announced
Risk Management: Stop-loss levels and position sizing considerations:
- Consider setting stop-loss at SMA 20 ($0.98) or lower Bollinger Band ($-0.93)
Please note that this analysis is based on the provided data, and it's essential to consider the limitations of the available information when making investment decisions.
Generated
News
All ENGNW news →
ENGNW Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 4.2638
Alpha: 104.30%
Correlation: 0.1938
R-Squared: 3.8%
Stock Volatility: 279.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 178
Period: 252 trading days
Data Points: 178
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
ENGNW Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
3 filers$72.94K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | GROUP ONE TRADING LLC Custodian | $28.55K | 39.13% | 2026-06-30 |
| 2 | Simplex Trading, LLC Custodian | $24.39K | 33.44% | 2026-06-30 |
| 3 | Millennium Management LLC Custodian | $20.00K | 27.42% | 2026-06-30 |
1 filers$76.47K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $76.47K | 100.00% | 2026-06-30 |
ENGNW Insider Trading (Form 4)
Latest: 2026-06-17Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Lota S. Zoth | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | Richard M Glickman | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | Wouter Joustra | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | William Grossman | Interim Chief Medical Officer | Grant (A) | +231,000 opt | — | EDGAR | |
| 2026-06-17 | Gerald A Brunk | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | Philip Astley-Sparke | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | Paul J Hastings | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-06-17 | Michael Thomas Heffernan | Director | Grant (A) | +31,000 opt | — | EDGAR | |
| 2026-02-03 | Ronald Harold Wilfred Cooper | CEO & President | Grant (A) | +801,000 opt | — | EDGAR | |
| 2026-02-03 | Alexander Julian Nichols | Chief Strategy & Ops. Ofc | Grant (A) | +195,000 opt | — | EDGAR | |
| 2026-02-03 | Joan Connolly | Chief Technology Officer | Grant (A) | +195,000 opt | — | EDGAR | |
| 2026-02-03 | Jill Buck | Chief Development Officer | Grant (A) | +195,000 opt | — | EDGAR | |
| 2026-02-03 | Matthew Ross Boyd | Chief Regulatory Officer | Grant (A) | +195,000 opt | — | EDGAR | |
| 2026-02-03 | Lee Giguere | Chief Legal Ofc. and Corp Secy | Grant (A) | +195,000 opt | — | EDGAR | |
| 2026-02-03 | Anthony Tzeyew Cheung | Chief Scientific Officer | Grant (A) | +195,000 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ENGNW Insider Holdings
5 insiders · @ $0.23
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Forbion Growth Management B.V. | 10%+ Owner | 6,798,362 | $1.56M | $16.03M | 2 | 2024-11-01 |
| 2 | Anthony Tzeyew Cheung | Chief Scientific Officer | 102,873 | $23.7K | $0 | 5 | 2026-02-03 |
| 3 | Gerald A Brunk | Director | 44,647 | $10.3K | $0 | 5 | 2026-06-17 |
| 4 | Richard M Glickman | Director | 24,675 | $5.7K | $0 | 5 | 2026-06-17 |
| 5 | Ronald Harold Wilfred Cooper | CEO & President | 10,000 | $2.3K | $57.0K | 4 | 2026-02-03 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.